Properties
Description
DB04760 inhibits MMPs, enzymes that degrade extracellular matrix components, thus having potential therapeutic applications in cancer and chronic inflammatory diseases. It targets MMP-13.
Molecular Formula
C22H20F2N4O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
DB04760 is used to inhibit matrix metalloproteinases, involved in extracellular matrix degradation, with implications in cancer and arthritis research.